Moderna (MRNA) Stock Plunges Over 10% Amid Insider Sales and Bearish Analyst Sentiment

Moderna (MRNA) shares plunged 10.7% to $68.39 amid $6.2M insider selling, missed EPS expectations, and a bearish "Reduce" rating from Wall Street.

The post Moderna (MRNA) Stock Plunges Over 10% Amid Insider Sales and Bearish Analyst Sentiment appeared first on Blockonomi.